Choosing wisely first line immunotherapy in non-small cell lung cancer (NSCLC): what to add and what to leave out
2019-01-01 Proto, C.; Ferrara, R; Signorelli, D.; Lo Russo, G.; Galli, G.; Imbimbo, M.; Prelaj, A.; Zilembo, N.; Ganzinelli, M.; Pallavicini, L. M.; De Simone, I.; Colombo, M. P.; Sica, A.; Torri, V.; Garassino, M. C.
Atypical patterns of response and progression in the era of immunotherapy combinations
2020-01-01 Ferrara, R; Matos, Ignacio
The Anti–Programmed Cell Death Protein-1/ Programmed Death-Ligand 1 Me-Too Drugs Tsunami: Hard To Be Millennials Among Baby Boomers
2023-01-01 Ferrara, R.; Ricciuti, B.; Ambrogio, C.; Trapani, D.
New technologies—the best is yet to come
2021-01-01 Pini, C.; Chiti, A.
Benefits and Harms of Lung Cancer Screening by Chest Computed Tomography: A Systematic Review and Meta-Analysis
2021-01-01 Passiglia, Francesco; Cinquini, Michela; Bertolaccini, Luca; Del Re, Marzia; Facchinetti, Francesco; Ferrara, R; Franchina, Tindara; Larici Anna, R.; Malapelle, Umberto; Menis, Jessica; Passaro, Antonio; Pilotto, Sara; Ramella, Sara; Rossi, Giulio; Trisolini, Rocco; Novello, Silvia
Is There an Interplay between Immune Checkpoint Inhibitors, Thromboprophylactic Treatments and Thromboembolic Events? Mechanisms and Impact in Non-Small Cell Lung Cancer Patients
2019-01-01 Nichetti, Federico; Ligorio, Francesca; Zattarin, Emma; Signorelli, Diego; Prelaj, Arsela; Proto, Claudia; Galli, Giulia; Marra, Antonio; Apollonio, Giulia; Porcu, Luca; de Braud, Filippo; Lo Russo, Giuseppe; Ferrara, R; Garassino Marina, Chiara
Treatment of advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines
2019-01-01 Passiglia, F.; Pilotto, S.; Facchinetti, F.; Bertolaccini, L.; Del Re, M.; Ferrara, R; Franchina, T.; Malapelle, U.; Menis, J.; Passaro, A.; Ramella, S.; Rossi, G.; Trisolini, R.; Novello, S.
Myeloid cell heterogeneity in lung cancer: implication for immunotherapy
2021-01-01 Sangaletti, Sabina; Ferrara, R; Tripodo, Claudio; Garassino Marina, Chiara; Colombo Mario, Paolo
Acquired hemophagocytic syndrome in a patient with synovial sarcoma: a case report
2015-01-01 C, Ciccarese; Ferrara, R; E, Fantinel; C, Zecchetto; F, Simionato; E, Grego; S, Ortolani; M, Caccese; D, Bimbatti; S, Cingarlini; M, Brunelli; A, Andreini; G, Tortora; F, Massari
Circulating innate immune markers and outcomes in treatment-naïve advanced non-small cell lung cancer patients
2019-01-01 Charrier, M.; Mezquita, L.; Lueza, B.; Dupraz, L.; Planchard, D.; Remon, J.; Caramella, C.; Cassard, L.; Boselli, L.; Reiners, K. S.; Pogge von Strandmann, E.; Rusakiewicz, S.; Ferrara, R; Duchemann, B.; Naigeon, M.; Pignon, J. P.; Besse, B.; Chaput, N.
Do immune checkpoint inhibitors need new studies methodology?
2018-01-01 Ferrara, R; Pilotto, Sara; Caccese, Mario; Grizzi, Giulia; Sperduti, Isabella; Giannarelli, Diana; Milella, Michele; Besse, Benjamin; Tortora, Giampaolo; Bria, Emilio
Poziotinib for EGFR and HER2 exon 20 insertion mutation in advanced NSCLC: Results from the expanded access program
2021-01-01 Prelaj, Arsela; Bottiglieri, Achille; Proto, Claudia; Lo Russo, Giuseppe; Signorelli, Diego; Ferrara, R; Galli, Giulia; De Toma, Alessandro; Viscardi, Giuseppe; Brambilla, Marta; Lobefaro, Riccardo; Nichetti, Federico; Manglaviti, Sara; Occhipinti, Mario; Labianca, Alice; Ganzinelli, Monica; Gallucci, Rosaria; Zilembo, Nicoletta; Greco Gabriella, Francesca; Torri, Valter; de Braud, Filippo; Garassino Marina, C.
Integrating clinical and biological prognostic biomarkers in patients with advanced NSCLC treated with immunotherapy: the DEMo score system
2020-01-01 Prelaj, Arsela; Proto, Claudia; Lo Russo, Giuseppe; Signorelli, Diego; Ferrara, R; Mensah, Mavis; Galli, Giulia; De Toma, Alessandro; Viscardi, Giuseppe; Brambilla, Marta; Lobefaro, Riccardo; Trevisan, Benedetta; Trovò, Francesco; Torri, Valter; Sozzi, Gabriella; Garassino Marina, Chiara; Boeri, Mattia
Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer
2021-01-01 Ferrara, R; Imbimbo, Martina; Malouf, Reem; Paget-Bailly, Sophie; Calais, François; Marchal, Corynne; Westeel, Virginie
Novel patterns of progression upon immunotherapy in other thoracic malignancies and uncommon populations
2021-01-01 Ferrara, R; Signorelli, Diego; Proto, Claudia; Prelaj, Arsela; Garassino Marina, Chiara; Lo Russo, Giuseppe
Is hyperprogressive disease a specific phenomenom of immunotherapy?
2020-01-01 Brambilla, Marta; Lo Russo, Giuseppe; Ferrara, R; Manglaviti, Sara; Garassino, Marina; Occhipinti, Mario
Harnessing oncology real-world data with AI
2023-01-01 Mahon, P.; Hall, G.; Dekker, A.; Vehreschild, J.; Tonon, G.
Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D
2017-01-01 Simbolo, Michele; Mafficini, Andrea; Sikora Katarzyna, O.; Fassan, Matteo; Barbi, Stefano; Corbo, Vincenzo; Mastracci, Luca; Rusev, Borislav; Grillo, Federica; Vicentini, Caterina; Ferrara, R; Pilotto, Sara; Davini, Federico; Pelosi, Giuseppe; Lawlor Rita, T.; Chilosi, Marco; Tortora, Giampaolo; Bria, Emilio; Fontanini, Gabriella; Volante, Marco; Scarpa, Aldo
Clarification of Definitions of Hyperprogressive Disease During Immunotherapy-Reply
2021-01-01 Caramella, Caroline; Ferrara, R; Besse, Benjamin
Tubulin inhibitors in non-small cell lung cancer: looking back and forward
2016-01-01 Ferrara, Roberto; Pilotto, Sara; Peretti, Umberto; Caccese, Mario; Kinspergher, Stefania; Carbognin, Luisa; Karachaliou, N; Rosell, R; Tortora, Giampaolo; Bria, Emilio
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Choosing wisely first line immunotherapy in non-small cell lung cancer (NSCLC): what to add and what to leave out | 1-gen-2019 | Proto, C.; Ferrara, R; Signorelli, D.; Lo Russo, G.; Galli, G.; Imbimbo, M.; Prelaj, A.; Zilembo, N.; Ganzinelli, M.; Pallavicini, L. M.; De Simone, I.; Colombo, M. P.; Sica, A.; Torri, V.; Garassino, M. C. | |
| Atypical patterns of response and progression in the era of immunotherapy combinations | 1-gen-2020 | Ferrara, R; Matos, Ignacio | |
| The Anti–Programmed Cell Death Protein-1/ Programmed Death-Ligand 1 Me-Too Drugs Tsunami: Hard To Be Millennials Among Baby Boomers | 1-gen-2023 | Ferrara, R.; Ricciuti, B.; Ambrogio, C.; Trapani, D. | |
| New technologies—the best is yet to come | 1-gen-2021 | Pini, C.; Chiti, A. | |
| Benefits and Harms of Lung Cancer Screening by Chest Computed Tomography: A Systematic Review and Meta-Analysis | 1-gen-2021 | Passiglia, Francesco; Cinquini, Michela; Bertolaccini, Luca; Del Re, Marzia; Facchinetti, Francesco; Ferrara, R; Franchina, Tindara; Larici Anna, R.; Malapelle, Umberto; Menis, Jessica; Passaro, Antonio; Pilotto, Sara; Ramella, Sara; Rossi, Giulio; Trisolini, Rocco; Novello, Silvia | |
| Is There an Interplay between Immune Checkpoint Inhibitors, Thromboprophylactic Treatments and Thromboembolic Events? Mechanisms and Impact in Non-Small Cell Lung Cancer Patients | 1-gen-2019 | Nichetti, Federico; Ligorio, Francesca; Zattarin, Emma; Signorelli, Diego; Prelaj, Arsela; Proto, Claudia; Galli, Giulia; Marra, Antonio; Apollonio, Giulia; Porcu, Luca; de Braud, Filippo; Lo Russo, Giuseppe; Ferrara, R; Garassino Marina, Chiara | |
| Treatment of advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines | 1-gen-2019 | Passiglia, F.; Pilotto, S.; Facchinetti, F.; Bertolaccini, L.; Del Re, M.; Ferrara, R; Franchina, T.; Malapelle, U.; Menis, J.; Passaro, A.; Ramella, S.; Rossi, G.; Trisolini, R.; Novello, S. | |
| Myeloid cell heterogeneity in lung cancer: implication for immunotherapy | 1-gen-2021 | Sangaletti, Sabina; Ferrara, R; Tripodo, Claudio; Garassino Marina, Chiara; Colombo Mario, Paolo | |
| Acquired hemophagocytic syndrome in a patient with synovial sarcoma: a case report | 1-gen-2015 | C, Ciccarese; Ferrara, R; E, Fantinel; C, Zecchetto; F, Simionato; E, Grego; S, Ortolani; M, Caccese; D, Bimbatti; S, Cingarlini; M, Brunelli; A, Andreini; G, Tortora; F, Massari | |
| Circulating innate immune markers and outcomes in treatment-naïve advanced non-small cell lung cancer patients | 1-gen-2019 | Charrier, M.; Mezquita, L.; Lueza, B.; Dupraz, L.; Planchard, D.; Remon, J.; Caramella, C.; Cassard, L.; Boselli, L.; Reiners, K. S.; Pogge von Strandmann, E.; Rusakiewicz, S.; Ferrara, R; Duchemann, B.; Naigeon, M.; Pignon, J. P.; Besse, B.; Chaput, N. | |
| Do immune checkpoint inhibitors need new studies methodology? | 1-gen-2018 | Ferrara, R; Pilotto, Sara; Caccese, Mario; Grizzi, Giulia; Sperduti, Isabella; Giannarelli, Diana; Milella, Michele; Besse, Benjamin; Tortora, Giampaolo; Bria, Emilio | |
| Poziotinib for EGFR and HER2 exon 20 insertion mutation in advanced NSCLC: Results from the expanded access program | 1-gen-2021 | Prelaj, Arsela; Bottiglieri, Achille; Proto, Claudia; Lo Russo, Giuseppe; Signorelli, Diego; Ferrara, R; Galli, Giulia; De Toma, Alessandro; Viscardi, Giuseppe; Brambilla, Marta; Lobefaro, Riccardo; Nichetti, Federico; Manglaviti, Sara; Occhipinti, Mario; Labianca, Alice; Ganzinelli, Monica; Gallucci, Rosaria; Zilembo, Nicoletta; Greco Gabriella, Francesca; Torri, Valter; de Braud, Filippo; Garassino Marina, C. | |
| Integrating clinical and biological prognostic biomarkers in patients with advanced NSCLC treated with immunotherapy: the DEMo score system | 1-gen-2020 | Prelaj, Arsela; Proto, Claudia; Lo Russo, Giuseppe; Signorelli, Diego; Ferrara, R; Mensah, Mavis; Galli, Giulia; De Toma, Alessandro; Viscardi, Giuseppe; Brambilla, Marta; Lobefaro, Riccardo; Trevisan, Benedetta; Trovò, Francesco; Torri, Valter; Sozzi, Gabriella; Garassino Marina, Chiara; Boeri, Mattia | |
| Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer | 1-gen-2021 | Ferrara, R; Imbimbo, Martina; Malouf, Reem; Paget-Bailly, Sophie; Calais, François; Marchal, Corynne; Westeel, Virginie | |
| Novel patterns of progression upon immunotherapy in other thoracic malignancies and uncommon populations | 1-gen-2021 | Ferrara, R; Signorelli, Diego; Proto, Claudia; Prelaj, Arsela; Garassino Marina, Chiara; Lo Russo, Giuseppe | |
| Is hyperprogressive disease a specific phenomenom of immunotherapy? | 1-gen-2020 | Brambilla, Marta; Lo Russo, Giuseppe; Ferrara, R; Manglaviti, Sara; Garassino, Marina; Occhipinti, Mario | |
| Harnessing oncology real-world data with AI | 1-gen-2023 | Mahon, P.; Hall, G.; Dekker, A.; Vehreschild, J.; Tonon, G. | |
| Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D | 1-gen-2017 | Simbolo, Michele; Mafficini, Andrea; Sikora Katarzyna, O.; Fassan, Matteo; Barbi, Stefano; Corbo, Vincenzo; Mastracci, Luca; Rusev, Borislav; Grillo, Federica; Vicentini, Caterina; Ferrara, R; Pilotto, Sara; Davini, Federico; Pelosi, Giuseppe; Lawlor Rita, T.; Chilosi, Marco; Tortora, Giampaolo; Bria, Emilio; Fontanini, Gabriella; Volante, Marco; Scarpa, Aldo | |
| Clarification of Definitions of Hyperprogressive Disease During Immunotherapy-Reply | 1-gen-2021 | Caramella, Caroline; Ferrara, R; Besse, Benjamin | |
| Tubulin inhibitors in non-small cell lung cancer: looking back and forward | 1-gen-2016 | Ferrara, Roberto; Pilotto, Sara; Peretti, Umberto; Caccese, Mario; Kinspergher, Stefania; Carbognin, Luisa; Karachaliou, N; Rosell, R; Tortora, Giampaolo; Bria, Emilio |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista1152
Data di pubblicazione
- In corso di stampa1
- 2020 - 2026740
- 2010 - 2019338
- 2000 - 200941
- 1990 - 199928
- 1985 - 19894
Editore
- MDPI43
- Elsevier B.V.38
- Frontiers Media S.A.31
- MDPI AG30
- Springer27
- Elsevier Inc.26
- Springer Science and Business Med...24
- W.B. Saunders22
- Elsevier Ltd21
- John Wiley and Sons Inc21
Rivista
- CANCERS23
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...23
- JOURNAL OF CARDIOTHORACIC AND VAS...16
- OTORINOLARINGOLOGIA13
- FRONTIERS IN IMMUNOLOGY12
- CANCER TREATMENT REVIEWS11
- CRITICAL REVIEWS IN ONCOLOGY HEMA...11
- EUROPEAN JOURNAL OF HEART FAILURE10
- EUROPEAN UROLOGY9
- JOURNAL OF THORACIC ONCOLOGY9
Keyword
- Humans184
- Animals50
- Male35
- COVID-1932
- Female25
- Treatment Outcome23
- SARS-CoV-220
- Adult18
- Biomarkers15
- Transplantation14
Lingua
- eng1078
- ita55
- spa3
- fre2
Accesso al fulltext
- no fulltext861
- reserved159
- open130
- partially open2